Clinical Study Of "Gumibao" Curing Non-Traumatic Necrosis Of Femoral Head In Early-Middle Metaphase

Purpose:according to review the outpatient records follow-up data and patients’ subjective description, observe the kidney invigorate the circulation of stock prescription encrypted on non traumatic avascular necrosis in the middle of the early clinical curative effect. Methods:according to the inclusion criteria and exclusion criteria, western medicine in March 2011 to December 2011 in suzhou fractures coco outpatient clinic of TCM hospital general data of 23 patients with ONFH, Harris and VAS score, records of the results of the imaging examination and so on in detail.Finally the income data and data into the computer, the establishment of database, statistical analysis.Results:1.30 patients with early metaphase ONFH VAS score, according to research by taking stock encrypted after treatment, the VAS score than before treatment significantly improved. (p<0.05)2. The comparison of the two groups of necrosis index score difference before and after the treatment, according to a study in terms of ease the process of femoral head necrosis, curative effect is better than that of intermittent groups.(P=0.014<0.014)3. The comparison of the two groups of curative effect before and after the treatment, according to the results in reducing bone marrow edema, joint effusion, improve the hip joint function and pain relief, stocks have good curative effect, but the last group of curative effect is not obvious advantages.(P>0.05)4. The hypothesis that stock encrypted treatment effect for the longer the treatment time, the better curative effect.Conclusion:1. The encrypted stocks pain in patients with middle patients with femoral head necrosis has exact curative effect.2. The encrypted stocks in terms of ease the process of femoral head necrosis, the duration gap is obviously better than the effect of drug use.3. Shares of middle encrypted to treat femoral head necrosis, the duration is intermittent medication in improving hip function, reduce bone marrow edema, relieve pain treatment has no obvious advantage, may be because the early to mid patients symptoms are not obvious, joint function intact, therapeutic effect without cause.